Literature DB >> 15246111

Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon.

Tom Samiric1, Mirna Z Ilic, Christopher J Handley.   

Abstract

Tendons are collagenous tissues made of mainly Type I collagen and it has been shown that the major proteoglycans of tendons are decorin and versican. Little is still known about the catabolism of these proteoglycans in tendon. Therefore, the aim of the study was to characterise the proteoglycans including their catabolic products present in uncultured bovine tendon and in the explant cultures of tendon. In this study, the proteoglycans were extracted from the tensile region of deep flexor tendon and isolated by ion-exchange chromatography and after deglycosylation analysed by SDS-polyacrylamide electrophoresis, Western blotting and amino-terminal amino acid sequence analysis. Based on amino acid sequence analysis, approximately 80% of the total proteoglycan core proteins in fresh tendon was decorin. Other species that were detected were biglycan and the large proteoglycans versican (splice variants V(0) and/or V(1)) and aggrecan. Approximately 35% of decorin present in the matrix showed carboxyl-terminal proteolytic processing at a number of specific sites. The analysis of small proteoglycans lost to the medium of tendon explants showed the presence of biglycan and decorin with the intact core protein as well as decorin fragments that contained the amino terminus of the core protein. In addition, two core protein peptides of decorin starting at residues K(171) and D(180) were observed in the matrix and one core protein with an amino-terminal sequence commencing at G(189) was isolated from the culture medium. The majority of the large proteoglycans present in the matrix of tendon were degraded and did not contain the G1 globular domain. Furthermore the aggrecan catabolites present in fresh tendon and lost to the medium of explants were derived from aggrecanase cleavage of the core protein at residues E(373)-A(374), E(1480)-G(1481) and E(1771)-A(1772). The analysis of versican catabolites (splice variants V(0) and/or V(1)) also showed evidence of degradation of the core protein by aggrecanase within the GAG-beta subdomain, as well as cleavage by other proteinase(s) within the GAG-alpha and GAG-beta subdomains of versican (variants V(0) and/or V(2)). Degradation products from the amino terminal region of type XII collagen were also detected in the matrix and medium of tendon explants. This work suggests a prominent role for aggrecanase enzymes in the degradation of aggrecan and to a lesser extent versican. Other unidentified proteinases are also involved in the degradation of versican and small leucine-rich proteoglycans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246111     DOI: 10.1016/j.matbio.2004.03.004

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  24 in total

1.  Adamts5-/- Mice Exhibit Altered Aggrecan Proteolytic Profiles That Correlate With Ascending Aortic Anomalies.

Authors:  Loren E Dupuis; E Lockett Nelson; Brittany Hozik; Sarah C Porto; Alexandra Rogers-DeCotes; Amanda Fosang; Christine B Kern
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-01       Impact factor: 8.311

Review 2.  Predictors of primary Achilles tendon ruptures.

Authors:  Femke M A P Claessen; Robert-Jan de Vos; Max Reijman; Duncan E Meuffels
Journal:  Sports Med       Date:  2014-09       Impact factor: 11.136

3.  Tendon structure and extracellular matrix components are affected by spasticity in cerebral palsy patients.

Authors:  Nicoletta Gagliano; Alessandra Menon; Carla Martinelli; Letizia Pettinari; Artemisia Panou; Aldo Milzani; Isabella Dalle-Donne; Nicola Marcello Portinaro
Journal:  Muscles Ligaments Tendons J       Date:  2013-05-21

4.  Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development.

Authors:  Susan M Smith; John M Whitelock; Renato V Iozzo; Christopher B Little; James Melrose
Journal:  Histochem Cell Biol       Date:  2009-08-11       Impact factor: 4.304

5.  Proteoglycans and catabolic products of proteoglycans present in ligament.

Authors:  Mirna Z Ilic; Phillip Carter; Alicia Tyndall; Jayesh Dudhia; Christopher J Handley
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

Review 6.  Tendon functional extracellular matrix.

Authors:  Hazel R C Screen; David E Berk; Karl E Kadler; Francesco Ramirez; Marian F Young
Journal:  J Orthop Res       Date:  2015-06       Impact factor: 3.494

7.  Regional molecular and cellular differences in the female rabbit Achilles tendon complex: potential implications for understanding responses to loading.

Authors:  Elise S Huisman; Gustav Andersson; Alexander Scott; Carol R Reno; David A Hart; Gail M Thornton
Journal:  J Anat       Date:  2014-02-26       Impact factor: 2.610

8.  Collagens, proteoglycans, MMP-2, MMP-9 and TIMPs in human achilles tendon rupture.

Authors:  Evgenia Karousou; Mario Ronga; Davide Vigetti; Alberto Passi; Nicola Maffulli
Journal:  Clin Orthop Relat Res       Date:  2008-04-19       Impact factor: 4.176

9.  Increased versican content is associated with tendinosis pathology in the patellar tendon of athletes with jumper's knee.

Authors:  A Scott; Ø Lian; C R Roberts; J L Cook; C J Handley; R Bahr; T Samiric; M Z Ilic; J Parkinson; D A Hart; V Duronio; K M Khan
Journal:  Scand J Med Sci Sports       Date:  2007-12-07       Impact factor: 4.221

Review 10.  Cell phenotypic variation in normal and damaged tendons.

Authors:  Peter D Clegg; Sandra Strassburg; Roger K Smith
Journal:  Int J Exp Pathol       Date:  2007-08       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.